Cargando…

Platelet miRNAs: differential expression in coronary artery disease and associations with course of left ventricular systolic function

BACKGROUND: MicroRNAs are paramount in post transcriptional gene regulation. We investigated platelet miRNAs in patients with CAD and examined potential associations with course of left ventricular ejection fraction (LVEF%). MATERIALS AND METHODS: In a first cohort, 62 MiRNAs were measured in platel...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldschmied, Andreas, Drotleff, Bernhard, Winter, Stefan, Schaeffeler, Elke, Schwab, Matthias, Gawaz, Meinrad, Geisler, Tobias, Rath, Dominik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339596/
https://www.ncbi.nlm.nih.gov/pubmed/37438691
http://dx.doi.org/10.1186/s12872-023-03362-0
_version_ 1785071881029681152
author Goldschmied, Andreas
Drotleff, Bernhard
Winter, Stefan
Schaeffeler, Elke
Schwab, Matthias
Gawaz, Meinrad
Geisler, Tobias
Rath, Dominik
author_facet Goldschmied, Andreas
Drotleff, Bernhard
Winter, Stefan
Schaeffeler, Elke
Schwab, Matthias
Gawaz, Meinrad
Geisler, Tobias
Rath, Dominik
author_sort Goldschmied, Andreas
collection PubMed
description BACKGROUND: MicroRNAs are paramount in post transcriptional gene regulation. We investigated platelet miRNAs in patients with CAD and examined potential associations with course of left ventricular ejection fraction (LVEF%). MATERIALS AND METHODS: In a first cohort, 62 MiRNAs were measured in platelets of 100 patients suffering from CAD. Expression profiles of individuals with chronic coronary syndrome (CCS) and MI were compared (CCS n = 67, MI n = 33). Also, associations between miRNA profiles and change in left ventricular ejection fraction (LVEF%) were investigated. In a second cohort of patients suffering from CCS (n = 10), MI (n = 11) or no CAD (n = 13), we measured miRNA expression in platelets, platelet supernatant and serum. This was carried out before and after in vitro platelet activation with CRP. RESULTS: Platelet miRNAs 103a-3p and 155-5p demonstrated higher expression in patients with CCS then in individuals with MI. Furthermore, multiple miRNAs were significantly higher expressed in matched controls compared to MI patients. 8 miRNAs showed higher expression in patients with improving LVEF% after a 1-year follow-up. In our second cohort, we found higher concentrations of 6 miRNAs in the platelet supernatant of patients with CCS, MI and no CAD after in vitro platelet activation. Most of these miRNAs showed a higher abundance in serum of MI patients as compared to CCS. CONCLUSION: Several miRNAs show higher expression in platelets of CCS compared to MI. After in vitro platelet activation, a release of multiple miRNAs out of the thrombocyte was observed. Furthermore, upregulation of serum miRNAs was found in MI patients when compared to CCS patients and individuals without CAD. Hence, platelets could present a source of upregulated circulating miRNAs in MI and additionally affect course of LVEF%. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12872-023-03362-0.
format Online
Article
Text
id pubmed-10339596
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103395962023-07-14 Platelet miRNAs: differential expression in coronary artery disease and associations with course of left ventricular systolic function Goldschmied, Andreas Drotleff, Bernhard Winter, Stefan Schaeffeler, Elke Schwab, Matthias Gawaz, Meinrad Geisler, Tobias Rath, Dominik BMC Cardiovasc Disord Research BACKGROUND: MicroRNAs are paramount in post transcriptional gene regulation. We investigated platelet miRNAs in patients with CAD and examined potential associations with course of left ventricular ejection fraction (LVEF%). MATERIALS AND METHODS: In a first cohort, 62 MiRNAs were measured in platelets of 100 patients suffering from CAD. Expression profiles of individuals with chronic coronary syndrome (CCS) and MI were compared (CCS n = 67, MI n = 33). Also, associations between miRNA profiles and change in left ventricular ejection fraction (LVEF%) were investigated. In a second cohort of patients suffering from CCS (n = 10), MI (n = 11) or no CAD (n = 13), we measured miRNA expression in platelets, platelet supernatant and serum. This was carried out before and after in vitro platelet activation with CRP. RESULTS: Platelet miRNAs 103a-3p and 155-5p demonstrated higher expression in patients with CCS then in individuals with MI. Furthermore, multiple miRNAs were significantly higher expressed in matched controls compared to MI patients. 8 miRNAs showed higher expression in patients with improving LVEF% after a 1-year follow-up. In our second cohort, we found higher concentrations of 6 miRNAs in the platelet supernatant of patients with CCS, MI and no CAD after in vitro platelet activation. Most of these miRNAs showed a higher abundance in serum of MI patients as compared to CCS. CONCLUSION: Several miRNAs show higher expression in platelets of CCS compared to MI. After in vitro platelet activation, a release of multiple miRNAs out of the thrombocyte was observed. Furthermore, upregulation of serum miRNAs was found in MI patients when compared to CCS patients and individuals without CAD. Hence, platelets could present a source of upregulated circulating miRNAs in MI and additionally affect course of LVEF%. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12872-023-03362-0. BioMed Central 2023-07-12 /pmc/articles/PMC10339596/ /pubmed/37438691 http://dx.doi.org/10.1186/s12872-023-03362-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Goldschmied, Andreas
Drotleff, Bernhard
Winter, Stefan
Schaeffeler, Elke
Schwab, Matthias
Gawaz, Meinrad
Geisler, Tobias
Rath, Dominik
Platelet miRNAs: differential expression in coronary artery disease and associations with course of left ventricular systolic function
title Platelet miRNAs: differential expression in coronary artery disease and associations with course of left ventricular systolic function
title_full Platelet miRNAs: differential expression in coronary artery disease and associations with course of left ventricular systolic function
title_fullStr Platelet miRNAs: differential expression in coronary artery disease and associations with course of left ventricular systolic function
title_full_unstemmed Platelet miRNAs: differential expression in coronary artery disease and associations with course of left ventricular systolic function
title_short Platelet miRNAs: differential expression in coronary artery disease and associations with course of left ventricular systolic function
title_sort platelet mirnas: differential expression in coronary artery disease and associations with course of left ventricular systolic function
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10339596/
https://www.ncbi.nlm.nih.gov/pubmed/37438691
http://dx.doi.org/10.1186/s12872-023-03362-0
work_keys_str_mv AT goldschmiedandreas plateletmirnasdifferentialexpressionincoronaryarterydiseaseandassociationswithcourseofleftventricularsystolicfunction
AT drotleffbernhard plateletmirnasdifferentialexpressionincoronaryarterydiseaseandassociationswithcourseofleftventricularsystolicfunction
AT winterstefan plateletmirnasdifferentialexpressionincoronaryarterydiseaseandassociationswithcourseofleftventricularsystolicfunction
AT schaeffelerelke plateletmirnasdifferentialexpressionincoronaryarterydiseaseandassociationswithcourseofleftventricularsystolicfunction
AT schwabmatthias plateletmirnasdifferentialexpressionincoronaryarterydiseaseandassociationswithcourseofleftventricularsystolicfunction
AT gawazmeinrad plateletmirnasdifferentialexpressionincoronaryarterydiseaseandassociationswithcourseofleftventricularsystolicfunction
AT geislertobias plateletmirnasdifferentialexpressionincoronaryarterydiseaseandassociationswithcourseofleftventricularsystolicfunction
AT rathdominik plateletmirnasdifferentialexpressionincoronaryarterydiseaseandassociationswithcourseofleftventricularsystolicfunction